Viral Load Dynamics in Plasma and Semen When Antiretroviral Therapy Is Initiated During Early HIV-1 Infection

被引:1
|
作者
Gilada, Trupti [1 ,2 ]
Ulrich, Angela K. [2 ,3 ]
Wang, Yixin [4 ]
Lama, Javier R. [5 ]
Alfaro, Ricardo [6 ]
Harb, Socorro
Daza, Glenda [7 ]
Holte, Sarah [8 ,9 ,10 ]
Pasalar, Siavash [4 ]
Rios, Jessica [11 ]
Ganoza, Carmela [12 ]
Dasgupta, Sayan [4 ]
Coombs, Robert W.
Duerr, Ann [4 ,8 ,9 ,13 ]
机构
[1] Unison Medicare & Res Ctr, Mumbai, India
[2] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA
[3] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN USA
[4] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[5] Asociac Civil Impacta Salud & Educ, Lima, Peru
[6] Ctr Invest Tecnol Biomed & Medioambientales, Lima, Peru
[7] Univ Washington, Sch Med, Seattle, WA USA
[8] Fred Hutchinson Canc Ctr, Publ Hlth Sci Div, Seattle, WA USA
[9] Univ Washington, Dept Global Hlth, Seattle, WA USA
[10] Univ Washington, Dept Biostat, Seattle, WA USA
[11] Pharmaceut Prod Dev Inc, Lima, Peru
[12] HIV Vaccine Trials Network, Lima, Peru
[13] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N, Mailstop M1-C108, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
HIV; viral load; antiretroviral therapy (ART); plasma; seminal plasma; blood; semen; SEMINAL PLASMA; DEPTH; UNCERTAINTY; VALIDATION; KINETICS; BLOOD;
D O I
10.1093/infdis/jiad520
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We assessed human immunodeficiency virus (HIV) load in plasma and semen during primary HIV infection using serial samples of semen and plasma during the first 24 weeks after diagnosis in untreated participants and those who started antiretroviral therapy (ART) immediately at diagnosis. In the absence of treatment, semen viral load was >1000 copies/mL in almost all specimens (83%) collected 2-10 weeks after the estimated date of HIV acquisition and remained >1000 copies/mL in 35% of untreated participants at the last observed time point. Thus, in the absence of ART, semen viral load remained at a level consistent with transmissibility throughout primary infection.
引用
收藏
页码:1141 / 1146
页数:6
相关论文
共 50 条
  • [31] Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants
    Uprety, Priyanka
    Chadwick, Ellen G.
    Rainwater-Lovett, Kaitlin
    Ziemniak, Carrie
    Luzuriaga, Katherine
    Capparelli, Edmund V.
    Yenokyan, Gayane
    Persaud, Deborah
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (12) : 1862 - 1870
  • [32] Viral dynamics of an HIV model with latent infection incorporating antiretroviral therapy
    Yan Wang
    Jun Liu
    Luju Liu
    Advances in Difference Equations, 2016
  • [33] Impact of Antiretroviral Therapy on HIV-1 Persistence: The Case for Early Initiation
    Hong, Feiyu F.
    Mellors, John W.
    AIDS REVIEWS, 2015, 17 (02) : 71 - 82
  • [34] Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts
    Hocqueloux, Laurent
    Avettand-Fenoel, Veronique
    Jacquot, Sophie
    Prazuck, Thierry
    Legac, Eric
    Melard, Adeline
    Niang, Mohamadou
    Mille, Catherine
    Le Moal, Gwenael
    Viard, Jean-Paul
    Rouzioux, Christine
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (05) : 1169 - 1178
  • [35] Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand
    Kroon, Eugene
    Pham, Phuc T.
    Sirivichayakul, Sunee
    Trichavaroj, Rapee
    Colby, Donn J.
    Pinyakorn, Suteeraporn
    Phanuphak, Nittaya
    Sanders-Buell, Eric
    van Griensven, Frits
    Kijak, Gustavo H.
    Kim, Jerome H.
    Michael, Nelson L.
    Robb, Merlin L.
    Ananworanich, Jintanat
    De Souza, Mark S.
    Tovanabutra, Sodsai
    AIDS, 2018, 32 (16) : 2373 - 2381
  • [36] The Dynamics of HIV-1 Adaptation in Early Infection
    da Silva, Jack
    GENETICS, 2012, 190 (03) : 1087 - 1099
  • [37] HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa
    Hoppe, Anne
    Giuliano, Marina
    Lugemwa, Abbas
    Thompson, Jennifer A.
    Floridia, Marco
    Walker, Ann S.
    Senoga, Ismail
    Abwola, Mary C.
    Pirillo, Maria F.
    Kityo, Cissy M.
    Arenas-Pinto, Alejandro
    Paton, Nicholas I.
    Agweng, E.
    Awio, P.
    Bakeinyaga, G.
    Isabirye, C.
    Kabuga, U.
    Kasuswa, S.
    Katuramu, M.
    Kityo, C.
    Kiweewa, F.
    Kyomugisha, H.
    Lutalo, E.
    Mugyenyi, P.
    Mulima, D.
    Musana, H.
    Musitwa, G.
    Musiime, V.
    Ndigendawan, M.
    Namata, H.
    Nkalubo, J.
    Labejja, P. Ocitti
    Okello, P.
    Olal, P.
    Pimundu, G.
    Segonga, P.
    Ssali, F.
    Tamale, Z.
    Tumukunde, D.
    Namala, W.
    Byaruhanga, R.
    Kayiwa, J.
    Tukamushaba, J.
    Abunyang, S.
    Eram, D.
    Denis, O.
    Lwalanda, R.
    Mugarura, L.
    Namusanje, J.
    Nankya, I.
    ANTIVIRAL THERAPY, 2018, 23 (02) : 191 - 195
  • [38] Effects of sliding mode control antiretroviral drug on HIV-1 viral load
    Ahmed, Musharif
    Zafar, Saad
    Saleem, Muhammad Aamer
    Zubair, Muhammad
    Qureshi, Ijaz Mansoor
    TURKISH JOURNAL OF ELECTRICAL ENGINEERING AND COMPUTER SCIENCES, 2020, 28 (06) : 3111 - 3125
  • [39] Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol
    Rusert, P
    Fischer, M
    Joos, B
    Leemann, C
    Kuster, H
    Flepp, M
    Bonhoeffer, S
    Günthard, HF
    Trkola, A
    VIROLOGY, 2004, 326 (01) : 113 - 129
  • [40] Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection
    Morrison, Charles S.
    Demers, Korey
    Kwok, Cynthia
    Bulime, Stanley
    Rinaldi, Anne
    Munjoma, Marshall
    Dunbar, Megan
    Chipato, Tsungai
    Byamugisha, Josaphat
    Van der Pol, Barbara
    Arts, Eric
    Salata, Robert A.
    AIDS, 2010, 24 (04) : 573 - U3